US Probes Merck's Marketing Of 3 Drugs
Merck & Co. Inc. disclosed Monday that the U.S. Department of Justice had asked it to turn over documents detailing marketing practices for cancer drugs Temodar and Intron A and hepatitis...To view the full article, register now.
Already a subscriber? Click here to view full article